Singapore markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.99+1.19 (+3.07%)
As of 10:22AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 55.11B
Enterprise value 34.35B
Trailing P/E N/A
Forward P/E 131.06
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)27.34
Price/book (mrq)6.92
Enterprise value/revenue 323.82
Enterprise value/EBITDA 7-15.11

Trading information

Stock price history

Beta (5Y monthly) -1.31
52-week change 39.42%
S&P500 52-week change 330.30%
52-week high 3141.01
52-week low 325.31
50-day moving average 344.72
200-day moving average 343.72

Share statistics

Avg vol (3-month) 3992.19k
Avg vol (10-day) 3865.9k
Shares outstanding 5130.61M
Implied shares outstanding 6N/A
Float 870.46M
% held by insiders 113.13%
% held by institutions 185.08%
Shares short (29 Sep 2021) 45.25M
Short ratio (29 Sep 2021) 46.11
Short % of float (29 Sep 2021) 47.54%
Short % of shares outstanding (29 Sep 2021) 44.02%
Shares short (prior month 30 Aug 2021) 45.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin -162.74%
Operating margin (ttm)-141.53%

Management effectiveness

Return on assets (ttm)-18.69%
Return on equity (ttm)-45.71%

Income statement

Revenue (ttm)182.71M
Revenue per share (ttm)1.43
Quarterly revenue growth (yoy)164.30%
Gross profit (ttm)-196.51M
EBITDA -253.67M
Net income avi to common (ttm)-297.36M
Diluted EPS (ttm)-2.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)826.06M
Total cash per share (mrq)6.32
Total debt (mrq)72.46M
Total debt/equity (mrq)9.83
Current ratio (mrq)5.91
Book value per share (mrq)5.65

Cash flow statement

Operating cash flow (ttm)-81.36M
Levered free cash flow (ttm)-26.26M